Diwakar Kumar

Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches

Deep Bhowmik, Rajat Nandi, Rahul Jagadeesan et al. · Infection Genetics and Evolution · 2020 · 136 citations · Full text

Virtual Screening, Medicine, Pharmacology +10

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis

Deep Bhowmik, Rajat Nandi, Amresh Prakash et al. · Heliyon · 2021 · 70 citations · Full text

Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach

Satabdi Saha, Rajat Nandi, Poonam Vishwakarma et al. · Frontiers in Pharmacology · 2021 · 31 citations · Full text

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CLpro and PLpro"

Deep Bhowmik, Ravi Datta Sharma, Amresh Prakash et al. · Journal of Molecular Structure · 2021 · 24 citations · Full text

Covid-19 Drug Candidates, Immunology, Antiviral Drug Development +6

Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of <i>Leishmania donovani</i> nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches

Deep Bhowmik, Rahul Jagadeesan, Praveen Rai et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 23 citations · Full text